Date 20 Dec 2021


EQRx aims to deliver medicines at lower prices by partnering with healthcare system actors and using cutting-edge technologies. The firm is located in Cambridge, MA.

NewsHeat chart

  • Week
  • Month
  • Year
  • Media news
  • Corp news
  • Combo news

The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice

Company Valuation

  • Valuation
  • Share Price
  • Cumulative Funding

The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.

Funding Round
Funding Amount
Post-Money Valuation
$  Share Price


Andreessen HorowitzAndreessen Horowitz
Casdin CapitalCasdin Capital
ARCH Venture PartnersARCH Venture Partners
Section 32Section 32

News related to EQRx

EQRxEQRx • 12 Sep 2022

AXSM Competitors 2022 | Axsome Therapeutics Alternatives

AXSM vs. VERV, RXDX, ARVN, EQRX, XENE, ROIV, PCRX, SAGE, BHC, and HCM. Should you be buying Axsome Therapeutics stock or one of its competitors?...
EQRxEQRx • 12 Sep 2022

Page 260 | Earnings Transcripts | Seeking Alpha

EQRx's (EQRX) CEO Melanie Nallicheri on Q4 2021 Results - Earnings Call Transcript · EQRXEQRXWSA TranscriptsWed, Mar. 23. SA Transcripts profile picture ...
EQRxEQRx • 8 Sep 2022

Checkpoint (CKPT): Strong Data, But Comes With Risks | Seeking ...

Recently, Eli Lilly (LLY) and EQRx (EQRX) have tried to bring Chinese PD-L1 inhibitors into the US market, however, the FDA has not been too kind, ...
Show more (327)